查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1208588

全球心肺壓力測試系統市場 - 按產品類型、最終用戶和地區市場規模、份額、趨勢分析、機會和預測（2019-2029 年）

Cardiopulmonary Stress Testing Systems Market- Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product Type ; By End-user ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 200 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

到 2029 年，全球心肺壓力測試系統市場規模將從 2022 年的 61 億美元增長到 89 億美元，在 2023 年至 2029 年的預測期內以 5.6% 的顯著複合年增長率增長。預計還會增長。

不斷增長的老年人口和冠狀動脈疾病（如急性心肌梗塞和心絞痛）的患病率上升是全球心肺壓力測試系統的主要增長動力。 此外，與生活方式相關的疾病和心肺疾病患病率的增加也推動了心肺壓力測試市場的發展。

本報告研究和分析了全球心肺壓力測試系統市場，提供了系統的信息，包括市場洞察力、細分市場和區域市場分析、競爭格局以及主要參與者的概況。

內容

第一章研究框架

第 2 章執行摘要

第 3 章全球心肺壓力測試系統市場洞察

  • 行業價值鏈分析
  • DROC 分析
    • 司機
      • 不斷增長的老年人口推動了市場增長
      • 心血管疾病患病率上升
    • 約束因素
      • 嚴格的規定
      • 在開發階段面臨更高的挑戰和昂貴的測試方法
    • 機會
      • 全球醫療支出不斷增長
    • 任務
      • COVID-19 的影響
  • 技術進步/最新發展
  • 監管框架
  • 波特的五力分析

第四章全球心肺壓力測試系統市場概況

  • 市場規模和價值預測（2019 年至 2029 年）
    • 按金額
  • 市場份額和預測
    • 按產品類型
      • 壓力血壓計
      • 運動測試系統
      • 壓力心電圖
      • 其他
    • 最終用戶
      • 醫院
      • 專科診所
      • 門診手術中心
      • 其他
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲
      • 中東和非洲 (MEA)

第五章北美心肺壓力測試系統市場

    • 市場規模和價值預測（2019 年至 2029 年）
    • 按金額
  • 市場份額和預測
    • 按產品類型
    • 最終用戶
    • 按國家
      • 美國
      • 加拿大

第6章歐洲心肺壓力測試系統市場

  • 市場規模和價值預測（2019 年至 2029 年）
    • 按金額
  • 市場份額和預測
    • 按產品類型
    • 最終用戶
    • 按國家
      • 德國
      • 英國
      • 意大利
      • 法國
      • 西班牙
      • 荷蘭
      • 其他歐洲

第 7 章亞太地區心肺壓力測試系統市場

  • 市場規模和價值預測（2019 年至 2029 年）
    • 按金額
  • 市場份額和預測
    • 按產品類型
    • 最終用戶
    • 按國家
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳大利亞和新西蘭
      • 印度尼西亞
      • 馬來西亞
      • 新加坡
      • 菲律賓
      • 越南
      • 其他亞太地區

第 8 章拉丁美洲心肺壓力測試系統市場

  • 市場規模和價值預測（2019 年至 2029 年）
    • 按金額
  • 市場份額和預測
    • 按產品類型
    • 最終用戶
    • 按國家
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第9章中東和非洲心肺壓力測試系統市場

  • 市場規模和價值預測（2019 年至 2029 年）
    • 按金額
  • 市場份額和預測
    • 按產品類型
    • 最終用戶
    • 按國家
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國
      • 卡塔爾
      • 科威特
      • 南非
      • 尼日利亞
      • 阿爾及利亞
      • 其他中東/非洲

第10章競爭格局

  • 主要公司和產品列表
  • 全球心肺負荷測試系統企業市場份額分析（2022年）
  • 競爭基準：按操作參數
  • 重大戰略發展（合併、收購、合作等）

第 11 章 COVID-19 對全球心肺壓力測試系統市場的影響

第12章公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人才、主要競爭對手、聯繫人、戰略展望、SWOT分析）

  • Thermo Fisher Scientific Ltd.
  • Philips Healthcare
  • Care Medical Ltd.
  • Cosmed Medical and Cardiac Science Corporation
  • GE Healthcare
  • Cardinal Health
  • CareFusion Corporation（BD）
  • Spacelabs Healthcare（OSI Systems, Inc.）
  • MGC Diagnostic Corporation
  • Nihon Kohden Corporation
  • Schiller AG
  • SunTech Medical, Inc.
  • Welch Allyn
  • Hill-Rom Holdings Inc
  • OSI Systems Inc
  • 其他

第 13 章關鍵戰略建議

第 14 章研究方法論

簡介目錄
Product Code: BWC23073

Global Cardiopulmonary Stress Testing Systems Market Size Expands to Touch USD 8.9 Billion by 2029

Global cardiopulmonary stress testing systems market is flourishing because of an increasing focus on diagnosing rapidly growing prevalence of cardiovascular diseases and geriatric population.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global cardiopulmonary stress testing systems market size at USD 6.1 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global cardiopulmonary stress testing systems market size to grow at a significant CAGR of 5.6% reaching a value of USD 8.9 billion by 2029. Major growth factors of global cardiopulmonary stress testing systems market include growing elder population and rising prevalence of coronary artery disorders such as acute myocardial infarction and angina pectoris. Moreover, rising rates of lifestyle diseases, as well as heart and lung ailments, are driving the cardiopulmonary stress testing market. The cardiopulmonary test assesses and diagnoses heart failure, ischemic heart disease, shortness of breath, and pulmonary problems. As of 2013, cardiovascular diseases were the leading cause of mortality worldwide, which has been a major concern for WHO and numerous healthcare organizations throughout the world and is also projected to drive the cardiopulmonary stress testing devices market during the forecast period. Apart from that, increasing budgetary allocation and the provision of affordable care to patients are on the rise. This has prompted market participants to establish operations new markets and implement technologically advanced testing processes. Therefore, such factors are expected to boost the expansion of the overall market. However, stringent regulations and higher challenges during the development stage and expensive testing procedures are anticipated to restrain the market growth during the period in analysis.

Global Cardiopulmonary Stress Testing Systems Market - Overview

The cardiopulmonary stress test is an evaluation that allows the physician to examine the heart and lungs' function during exercise. The amount of oxygen a person consumes when riding a bike or walking on a treadmill is used to evaluate disorders such as dyspnea, hypertrophic cardiomyopathy, and pulmonary hypertension. The increased prevalence of cardiovascular illnesses and pulmonary ailments is a primary driver of market expansion. One of the primary causes leading to the expansion is an increase in the global prevalence of numerous cardiovascular indications, such as atrial fibrillation, which necessitates the testing of cardiopulmonary function. Furthermore, the increased prevalence of lifestyle diseases, as well as heart and lung disorders, is propelling the cardiopulmonary stress testing market. The cardiopulmonary test evaluates and detects cardiac failures, ischemic heart disease, shortness of breath, and pulmonary issues. The expanding geriatric population is one of the market's primary drivers. According to the United Nations, by 2050, elderly people will make up more than 25% of the population in Europe and North America; 20% in Oceania; 17% in Asia, Latin America, and the Caribbean; and 6% in Africa.

Impact of COVID-19 on Global Cardiopulmonary Stress Testing Systems Market

COVID-19 had a minor impact on the market for cardiopulmonary stress testing systems. It is the most common type of cardiac surgery performed worldwide, and it is a life-saving technique for individuals with serious heart illness and pulmonary disease. Hospitalizations for arrhythmia, heart failure, ischemic heart disease, dyspnea, and heart valve imbalance decreased dramatically as a result of the pandemic. Furthermore, the pandemic is disrupting the medical supply chain, and many enterprises will shift to other geographic zones in the future to assure product availability and supply chain protection. As a result, the COVID-19 pandemic has had an impact on the market. However, the situation is predicted to steadily improve over the forecast period.

Global Cardiopulmonary Stress Testing Systems Market - By Product Type

By product type, global cardiopulmonary stress testing systems market is segmented into Stress Blood Pressure Monitors, Exercise Testing Systems, and Stress ECG. The exercise testing systems segment is expected to hold the highest market share due to its precision and short running duration. Furthermore, the rising choice for these systems by physicians and patients due to their cost-effectiveness and diverse applications contributes to the rise in adoption of these systems, propelling market expansion. However, the stress ECG device segment is establishing its dominance in the global cardiopulmonary stress testing systems market over the projected period due to an increasing senior population with diminishing functional capability. Schiller AG is the global market leader in cardiopulmonary stress testing services. The product pipeline and technology for patient assessment via stress testing at the company have been continuously developed. The CARDIOVIT AT-200 EXCELLENCE ERGOSPIRO is a device that can conveniently and reliably perform both pulmonary function tests (PFTs) and metabolic tests with diagnostic quality-12 or 16-lead exercise ECG.

Competitive Landscape:

Major players operating in global cardiopulmonary stress testing systems market include Thermo Fisher Scientific Ltd., Philips Healthcare, Care Medical Ltd., Cosmed Medical and Cardiac Science Corporation, GE Healthcare, Cardinal Health, CareFusion Corporation (BD), Spacelabs Healthcare (OSI Systems, Inc.), MGC Diagnostic Corporation, Nihon Kohden Corporation, Schiller AG, SunTech Medical, Inc., Welch Allyn, Hill-Rom Holdings Inc, and OSI Systems Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Cardiopulmonary Stress Testing Systems Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Cardiopulmonary Stress Testing Systems Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Cardiopulmonary Stress Testing Systems Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rise in Geriatric Population Boost Market Growth
      • 3.2.1.2. Rising Prevalence of Cardiovascular Diseases
    • 3.2.2. Restraints
      • 3.2.2.1. Stringent Regulations
      • 3.2.2.2. Higher Challenges During the Development Stage and Expensive Testing Procedures
    • 3.2.3. Opportunities
      • 3.2.3.1. Rise in Global Healthcare Expenditure
    • 3.2.4. Challenges
      • 3.2.4.1. Impact of COVID-19
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Cardiopulmonary Stress Testing Systems Market Overview

  • 4.1. Market Size & Forecast, by Value, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product Type
      • 4.2.1.1. Stress Blood Pressure Monitors
      • 4.2.1.2. Exercise Testing Systems
      • 4.2.1.3. Stress ECG
      • 4.2.1.4. Others
    • 4.2.2. By End-user
      • 4.2.2.1. Hospitals
      • 4.2.2.2. Specialty Clinics
      • 4.2.2.3. Ambulatory Surgical Centers
      • 4.2.2.4. Others
    • 4.2.3. By Region
      • 4.2.3.1. North America
      • 4.2.3.2. Europe
      • 4.2.3.3. Asia Pacific (APAC)
      • 4.2.3.4. Latin America
      • 4.2.3.5. Middle East and Africa (MEA)

5. North America Cardiopulmonary Stress Testing Systems Market

    • 5.1.1. Market Size & Forecast, by Value, 2019-2029
    • 5.1.2. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type
    • 5.2.2. By End-user
    • 5.2.3. By Country
      • 5.2.3.1. US
      • 5.2.3.1.1. By Product Type
      • 5.2.3.1.2. By End-user
      • 5.2.3.2. Canada
      • 5.2.3.2.1. By Product Type
      • 5.2.3.2.2. By End-user

6. Europe Cardiopulmonary Stress Testing Systems Market

  • 6.1. Market Size & Forecast, by Value, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End-user
    • 6.2.3. By Country
      • 6.2.3.1. Germany
      • 6.2.3.1.1. By Product Type
      • 6.2.3.1.2. By End-user
      • 6.2.3.2. United Kingdom
      • 6.2.3.2.1. By Product Type
      • 6.2.3.2.2. By End-user
      • 6.2.3.3. Italy
      • 6.2.3.3.1. By Product Type
      • 6.2.3.3.2. By End-user
      • 6.2.3.4. France
      • 6.2.3.4.1. By Product Type
      • 6.2.3.4.2. By End-user
      • 6.2.3.5. Spain
      • 6.2.3.5.1. By Product Type
      • 6.2.3.5.2. By End-user
      • 6.2.3.6. The Netherlands
      • 6.2.3.6.1. By Product Type
      • 6.2.3.6.2. By End-user
      • 6.2.3.7. Rest of Europe
      • 6.2.3.7.1. By Product Type
      • 6.2.3.7.2. By End-user

7. Asia Pacific Cardiopulmonary Stress Testing Systems Market

  • 7.1. Market Size & Forecast, by Value, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End-user
    • 7.2.3. By Country
      • 7.2.3.1. China
      • 7.2.3.1.1. By Product Type
      • 7.2.3.1.2. By End-user
      • 7.2.3.2. India
      • 7.2.3.2.1. By Product Type
      • 7.2.3.2.2. By End-user
      • 7.2.3.3. Japan
      • 7.2.3.3.1. By Product Type
      • 7.2.3.3.2. By End-user
      • 7.2.3.4. South Korea
      • 7.2.3.4.1. By Product Type
      • 7.2.3.4.2. By End-user
      • 7.2.3.5. Australia & New Zealand
      • 7.2.3.5.1. By Product Type
      • 7.2.3.5.2. By End-user
      • 7.2.3.6. Indonesia
      • 7.2.3.6.1. By Product Type
      • 7.2.3.6.2. By End-user
      • 7.2.3.7. Malaysia
      • 7.2.3.7.1. By Product Type
      • 7.2.3.7.2. By End-user
      • 7.2.3.8. Singapore
      • 7.2.3.8.1. By Product Type
      • 7.2.3.8.2. By End-user
      • 7.2.3.9. Philippines
      • 7.2.3.9.1. By Product Type
      • 7.2.3.9.2. By End-user
      • 7.2.3.10. Vietnam
      • 7.2.3.10.1. By Product Type
      • 7.2.3.10.2. By End-user
      • 7.2.3.11. Rest of Asia Pacific
      • 7.2.3.11.1. By Product Type
      • 7.2.3.11.2. By End-user

8. Latin America Cardiopulmonary Stress Testing Systems Market

  • 8.1. Market Size & Forecast, by Value, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End-user
    • 8.2.3. By Country
      • 8.2.3.1. Brazil
      • 8.2.3.1.1. By Product Type
      • 8.2.3.1.2. By End-user
      • 8.2.3.2. Mexico
      • 8.2.3.2.1. By Product Type
      • 8.2.3.2.2. By End-user
      • 8.2.3.3. Argentina
      • 8.2.3.3.1. By Product Type
      • 8.2.3.3.2. By End-user
      • 8.2.3.3.3. By Drive Type
      • 8.2.3.4. Peru
      • 8.2.3.4.1. By Product Type
      • 8.2.3.4.2. By End-user
      • 8.2.3.5. Rest of Latin America
      • 8.2.3.5.1. By Product Type
      • 8.2.3.5.2. By End-user

9. Middle East & Africa Cardiopulmonary Stress Testing Systems Market

  • 9.1. Market Size & Forecast, by Value, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End-user
    • 9.2.3. By Country
      • 9.2.3.1. Saudi Arabia
      • 9.2.3.1.1. By Product Type
      • 9.2.3.1.2. By End-user
      • 9.2.3.2. UAE
      • 9.2.3.2.1. By Product Type
      • 9.2.3.2.2. By End-user
      • 9.2.3.3. Qatar
      • 9.2.3.3.1. By Product Type
      • 9.2.3.3.2. By End-user
      • 9.2.3.4. Kuwait
      • 9.2.3.4.1. By Product Type
      • 9.2.3.4.2. By End-user
      • 9.2.3.5. South Africa
      • 9.2.3.5.1. By Product Type
      • 9.2.3.5.2. By End-user
      • 9.2.3.6. Nigeria
      • 9.2.3.6.1. By Product Type
      • 9.2.3.6.2. By End-user
      • 9.2.3.7. Algeria
      • 9.2.3.7.1. By Product Type
      • 9.2.3.7.2. By End-user
      • 9.2.3.8. Rest of Middle East & Africa
      • 9.2.3.8.1. By Product Type
      • 9.2.3.8.2. By End-user

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Cardiopulmonary Stress Testing Systems Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

11. Impact of Covid-19 on Global Cardiopulmonary Stress Testing Systems Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Thermo Fisher Scientific Ltd.
  • 12.2. Philips Healthcare
  • 12.3. Care Medical Ltd.
  • 12.4. Cosmed Medical and Cardiac Science Corporation
  • 12.5. GE Healthcare
  • 12.6. Cardinal Health
  • 12.7. CareFusion Corporation (BD)
  • 12.8. Spacelabs Healthcare (OSI Systems, Inc.)
  • 12.9. MGC Diagnostic Corporation
  • 12.10. Nihon Kohden Corporation
  • 12.11. Schiller AG
  • 12.12. SunTech Medical, Inc.
  • 12.13. Welch Allyn
  • 12.14. Hill-Rom Holdings Inc
  • 12.15. OSI Systems Inc
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations